Conference Coverage

ASCO: Omitting adjuvant radiation after pCR ups locoregional recurrence risk


 

AT THE 2015 ASCO ANNUAL MEETING

References

Multivariate analysis here again showed that radiation therapy independently predicted better locoregional recurrence–free survival (HR, 0.56; P = .029) but not disease-free survival.

Pages

Recommended Reading

VIDEO: Palbociclib may delay chemotherapy for some women with metastatic breast cancer
Breast Cancer ICYMI
CDK inhibitor remains active as endocrine resistance emerges
Breast Cancer ICYMI
Anastrozole provides alternative option for DCIS
Breast Cancer ICYMI
ASCO: Adjuvant neratinib has payoff in HER2-positive breast cancer
Breast Cancer ICYMI
ASCO: Precision medicine initiatives take wing
Breast Cancer ICYMI
Three bisphosphonates found on par in early breast cancer
Breast Cancer ICYMI
VIDEO: Dr. William J. Gradishar provides take-home messages from ASCO 2015
Breast Cancer ICYMI
ASCO: Enzalutamide advances in triple-negative breast cancer
Breast Cancer ICYMI
Advanced breast cancer: paclitaxel bests nab-paclitaxel, ixabepilone
Breast Cancer ICYMI
David Henry's JCSO podcast, May 2015
Breast Cancer ICYMI